In Treatment of Anxiety disorder Etpro 0.25mg/20mg Tablet is thought to work by stopping your brain from releasing the chemicals that make you feel anxious so it can reduce the symptoms of excessive anxiety and worry. It can also reduce feelings of restlessness, tiredness, difficulty concentrating, feeling irritable and sleep problems that often come with Anxiety disorder. It will therefore help you go about your daily activities more easily and be more productive. Keep taking this medicine even if you feel well. Stopping suddenly can cause serious problems.
It is unsafe to consume alcohol with Etpro 0.25mg/20mg Tablet.
Etpro 0.25mg/20mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Etpro 0.25mg/20mg Tablet during breastfeeding is not available. Please consult your doctor.
Etpro 0.25mg/20mg Tablet may cause side effects which could affect your ability to drive. Etpro 0.25mg/20mg Tablet may cause visual disturbances, hallucinations, fatigue, mental confusion, dizziness or tiredness. This may affect your driving ability.
There is limited information available on the use of Etpro 0.25mg/20mg Tablet in patients with kidney disease. Please consult your doctor.
Etpro 0.25mg/20mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Etpro 0.25mg/20mg Tablet may be needed. Please consult your doctor. Regular monitoring of blood pressure is advisable for dose adjustment.
If you miss a dose of Etpro 0.25mg/20mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Unimarck Pharma India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Global Care || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Macleods Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Solarium Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Unimarck Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Placker Life Sciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Humbing Ethicals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Organic Laboratories || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Thyone Health Care || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Freedom Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)